Search results
Biogen trims pipeline programs to cut costs, focus on Alzheimer's drug launch
Reuters via Yahoo Finance· 1 year agoBiogen Inc said on Tuesday it will pause or discontinue at least four studies of experimental drugs...
Biogen confident in Alzheimer's drug ahead of rivals' data
Reuters via Yahoo News· 2 years ago(Reuters) -Biogen Inc on Tuesday said the Alzheimer's disease drug it is developing with Japan's...
Biogen: Don’t expect any big acquisitions this year
BioPharma Dive via Yahoo Finance· 2 months agoWhile the company is eager to diversify, CEO Chris Viehbacher said any near-term dealmaking would likely focus on collaborations and early-stage assets.
Biogen (BIIB) Q4 2022 Earnings Call Transcript
Motley Fool· 1 year agoAt this time, I would like to welcome everyone to the Biogen fourth quarter and full year 2022 earnings call and business update. On today's call, I am...
Biogen leans on new Alzheimer's drug to calm investor worries
Reuters via Yahoo Finance· 2 years ago(Reuters) -Biogen Inc on Wednesday tried to assuage investor worries by laying out a plan for its...
Q4 2023 Biogen Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 months agoParticipants Charles E. Triano; Senior VP & Head of IR; Biogen Inc. Christopher A. Viehbacher; President, CEO & Director; Biogen Inc. Michael R. McDonnell; Executive VP & CFO; Biogen Inc. Priya ...
